LookCloser.aipublic supplement evidence
Exact product checked · GTIN 00886790326540Benefiber · checked Jul 21, 2026 · on sale since Jan 18, 2023🇨🇭 USPTO wordmark owner · Novartis AG · SWITZERLAND
Quick read · Benefiber

Benefiber Prebiotic GLP-1 Friendly Fiber Supplement Gummies for…

Checked against public sources between July 21 and July 24, 2026 · LookCloser does not sell or recommend supplements.

81gummies

Does the marketing hold up?

FDA recall appears in this brand's history. An exact-product recall is a direct signal. A different product from the same firm is company context, not a strike against this item.

Is the dose real?Can’t check — no panel filed
What a serving costsNo price found for this exact barcode
Is it tested?No testing claim made
Who’s behind it?🇨🇭Novartis AGother · SWITZERLAND
Is it the real thing?Barcode matches outside records
Trouble on record?Brand history — not this product
Quick read · 2 useful findings

What is worth knowing.

Headlines first. Open evidence only when you want the source trail.

Needs explanationAny trouble in public records?

FDA recall appears in this brand's history

An exact-product recall is a direct signal. A different product from the same firm is company context, not a strike against this item.

Evidence and sources

This recall is not about the product on this page. Novartis Consumer Health recalled a different product on August 6, 2013. FDA has since closed that case. The recalled item was “Benefiber, Fiber Supplement, Assorted Fruit, Sugar Free, 100ct chewable tablets.…”

Locked evidence record →Open the full source-linked finding
CheckedWho is behind it?

The barcode identity checks out · 886790326540.

The barcode matches, so we are checking the right product rather than a look-alike.

Evidence and sources

Open Food Facts resolves 886790326540 to "Fiber Gummies" (Benefiber) — consistent with this listing.

Locked evidence record →Open the full source-linked finding
What remains open 1
  • We have not found a public label filing for this exact product.

These are evidence gaps, not strikes against the product.

Who owns the brand wordmark?
🇨🇭
Novartis AGOther · exact supplement-class mark for BENEFIBER
Registration3843122
Registered2010-08-31
AssignmentsYes

Filed address
CH 4002, Basel, SWITZERLAND

USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗

Research behind the findings

Dose and research context

We could not match an amount on this product to a studied range for the same ingredient, so these links are ingredient background rather than a measurement of this product.

Where it sells

Price check for this exact product

Amazon

Exact UPC/GTIN match
$16.12

4.6/5 · 4,819 ratings

matching UPC/GTIN · checked Sep 1, 2026

View on Amazon ↗

iHerb

Not confirmed
No exact listing saved

We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.

Search iHerb ↗

Target

Not confirmed
No exact listing saved

We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.

Search Target ↗

Walmart

Not confirmed
No exact listing saved

We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.

Search Walmart ↗

Only one exact price was available at build time; prices change by date, seller, and promotion.

Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.

Want to inspect the evidence?

The full report shows every source, the exact unresolved question, and the documentation that would settle it.

Read / share full evidence →

Record built September 03, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.